Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population

• Hoofdauteurs: Rebecca K. Hollenberg (Auteur), Diane R. Krieger (Auteur), Robert Samuels (Auteur), Kim Kraynyak (Auteur), Albert Sylvester (Auteur), Matthew Morrow (Auteur), Jean Boyer (Auteur), Michael Dallas (Auteur), Prakash K. Bhuyan (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2020-06-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

HPV remains the most common sexually transmitted disease worldwide, despite improvements in awareness, screening, prophylactic vaccination uptake, and surgical treatment. VGX-3100 is an immunotherapy that uses electroporation to introduce DNA encoding for modified HPV-16 and HPV-18, E6-and E7 protei...